These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16167043)

  • 1. The role of transplant in multiple myeloma.
    Barlogie B
    Clin Adv Hematol Oncol; 2005 Aug; 3(8):604-6. PubMed ID: 16167043
    [No Abstract]   [Full Text] [Related]  

  • 2. Tandem bone marrow transplantation in multiple myeloma.
    Chng WJ
    N Engl J Med; 2004 Apr; 350(14):1466-7; author reply 1466-7. PubMed ID: 15074003
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of hematopoietic stem cell autotransplantation in the treatment of multiple myeloma: initial experience at the National Bone Marrow Transplantation Center and review of the literature].
    Abdelkefi A; Ladeb S; Ben Othman T; Torjman L; Jeddi R; Ben Abdeladhim A
    Tunis Med; 2000 Oct; 78(10):548-56. PubMed ID: 11190737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal dosing of melphalan as high-dose therapy before autologous hematopoietic stem cell transplantation in myeloma patients with solitary kidney: a case series.
    Nooka AK; Harvey RD; Langston A; Collins H; Lonial S; Kaufman JL
    Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):e59-63. PubMed ID: 24378319
    [No Abstract]   [Full Text] [Related]  

  • 5. Melphalan-based autologous transplant in octogenarian multiple myeloma patients.
    Saini NY; Patel R; Varma A; Bashir Q; Delgado R; Rondon G; Popat UR; Hosing CM; Nieto Y; Kebriaei P; Alousi AM; Ahmed S; Weber DM; Thomas SK; Lee HC; Manasanch EE; Patel KK; Orlowski RZ; Champlin RE; Qazilbash MH
    Am J Hematol; 2019 Jan; 94(1):E2-E5. PubMed ID: 30300461
    [No Abstract]   [Full Text] [Related]  

  • 6. In focus: (166) Ho-DOTMP in the pretransplant treatment of multiple myeloma.
    Clapp K
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):753-4. PubMed ID: 16170894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
    Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
    J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autologous transplantation of peripheral hematopoietic cells in a patient with multiple myeloma and renal insufficiency].
    Krejcí M; Doubek M; Adam Z; Hájek R; Vorlícek J; Mayer J
    Vnitr Lek; 1997 Nov; 43(11):756-8. PubMed ID: 9650509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous hematopoietic stem-cell transplantation for multiple myeloma.
    Harousseau JL; Moreau P
    N Engl J Med; 2009 Jun; 360(25):2645-54. PubMed ID: 19535803
    [No Abstract]   [Full Text] [Related]  

  • 10. [IgD myeloma].
    Takahashi T; Imai K
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):408-10. PubMed ID: 9851174
    [No Abstract]   [Full Text] [Related]  

  • 11. Rationale for adjuvant idiotypic vaccination after high-dose therapy for multiple myeloma.
    Reichardt VL; Okada CY; Stockerl-Goldstein KE; Bogen B; Levy R
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):157-63. PubMed ID: 9310193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple myeloma.
    Holstein SA; Liu H; McCarthy PL
    Hematol Oncol Clin North Am; 2014 Dec; 28(6):1113-29. PubMed ID: 25459182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple myeloma.
    Gul Z; Bashir Q; Cremer M; Yusuf SW; Gunaydin H; Arora S; Slone S; Nieto Y; Sherwani N; Parmar S; Shah N; Dinh YT; Hosing CM; Popat UR; Kebriaei P; Shpall EJ; Giralt SA; Champlin RE; Qazilbash MH
    Leuk Lymphoma; 2015 Feb; 56(2):533-5. PubMed ID: 24882259
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of multiple myeloma.
    Singhal S
    BMJ; 2003 Sep; 327(7415):575-6. PubMed ID: 12969901
    [No Abstract]   [Full Text] [Related]  

  • 15. A rare case of interstitial pneumonitis after tandem high-dose melphalan conditioning and autologous stem cell transplantation in multiple myeloma.
    Buxhofer-Ausch V; Ruckser R; Kier P; Habertheuer KH; Zelenka P; Tatzreiter G; Ausch C; Schmid I; Hruby W; Reiner-Concin A; Sebesta C; Ogris E; Hinterberger-Fischer M; Hinterberger W
    Eur J Haematol; 2004 Aug; 73(2):143-6. PubMed ID: 15245515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma.
    Thompson PA; Prince HM; Seymour JF; Ritchie D; Stokes K; Burbury K; Wolf M; Peinert S; Joyce T; Harrison SJ
    Bone Marrow Transplant; 2011 May; 46(5):764-5. PubMed ID: 20676149
    [No Abstract]   [Full Text] [Related]  

  • 17. Single-agent high-dose melphalan followed by peripheral blood stem cell (PBSC) in lymphoma patients: an effective, and well-tolerated conditioning regimen.
    Magagnoli M; Castagna L; Bramanti S; Balzarotti M; Santoro A
    Bone Marrow Transplant; 2004 May; 33(10):1067-8. PubMed ID: 15129236
    [No Abstract]   [Full Text] [Related]  

  • 18. Results of a retrospective single institution analysis of targeted skeletal radiotherapy with (166)Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma. Impact on transplant outcomes.
    Christoforidou AV; Saliba RM; Williams P; Qazilbash M; Roden L; Aleman A; Weber D; Mendoza F; Podoloff D; Wendt R; Breitz H; Alexanian R; Champlin R; Giralt S
    Biol Blood Marrow Transplant; 2007 May; 13(5):543-9. PubMed ID: 17448913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nutritional pathway for autologous stem cell transplantation].
    Aoyama T; Imataki O; Inoue N; Katsumata M; Katsuta T; Kataoka T; Yoshida T; Mochizuki T; Motokawa S; Tamai Y; Hagiwara S; Kawakami K
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1249-53. PubMed ID: 17687206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of high-dose melphalan and autologous stem cell transplant in the rapidly evolving era of modern multiple myeloma therapy.
    Voorhees PM; Usmani SZ
    Clin Adv Hematol Oncol; 2016 Sep; 14(9):719-28. PubMed ID: 27673290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.